FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to an anti-Igβ antibody. Also disclosed is a polynucleotide encoding said antibody, an expression vector comprising said polynucleotide, a host cell for producing said antibody, a pharmaceutical composition containing said antibody. Disclosed is a method of producing said antibody, a method for preventing or treating a disease associated with Igβ, using said antibody.
EFFECT: invention has the ability effectively treat diseases associated with Igβ.
34 cl, 8 ex, 1 tbl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEW ANTI-HUMAN TIE-2 ANTIBODY | 2015 |
|
RU2702553C2 |
| NEW ANTIBODY TO TSLP-RECEPTOR OF HUMAN | 2014 |
|
RU2689528C2 |
| ANTIBODY AGAINST HUMAN FN14 | 2019 |
|
RU2787044C2 |
| ANTIBODY TO HUMAN CD73 | 2017 |
|
RU2754058C2 |
| A NEW FAB FRAGMENT OF AN ANTIBODY AGAINST HUMAN CEACAM5 | 2018 |
|
RU2779165C2 |
| HUMANISED HUMAN OSTEOPONTIN ANTIBODY | 2007 |
|
RU2429016C2 |
| IMPROVED HUMANISED ANTIBODY TO HUMAN α9-INTEGRIN | 2009 |
|
RU2503720C2 |
| NOVEL FAB FRAGMENT OF ANTI-HUMAN MUC1 ANTIBODY | 2017 |
|
RU2767793C2 |
| COMPLEX CONTAINING Fab FRAGMENT OF ANTI-HUMAN MUC1 ANTIBODY, PEPTIDE LINKER AND/OR LIGAND | 2019 |
|
RU2814073C2 |
| Siglec-15 ANTIBODY | 2010 |
|
RU2539790C2 |
